Retatrutide's Phase 2, published in the New England Journal of Medicine in 2023, reported approximately 24.2% at 48 weeks (12 mg), and the Phase 3 TRIUMPH-1 readout in 2026 reported near 28% at 80 weeks
Cautions for the wider drug class Class-level Approved GLP-1 medicines carry label warnings about pancreas inflammation, gallbladder problems, thyroid tumours seen in rodent studies, and low blood sugar when combined with insulin or sulfonylureas (a diabetes drug group)
G., Mark, T., Rasmussen, S., & Lingvay, I
Incorporating these into your meals and snacks can help bridge the gap if you struggle to drink enough water
Goel typically recommends a loading protocol (35 sessions over 12 weeks) followed by monthly maintenance
Start your intake Why Semaglutide Causes Nausea and Vomiting Semaglutide works by mimicking glucagon-like peptide-1, a hormone that slows stomach emptying and signals fullness to your brain